NEBIVOLOL HCI | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

NEBIVOLOL HCI

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 15 USDMF, 7 CEP/COS, 6 EU WC, 12 KDMF, 9 NDC API, 28 Listed Suppliers, $ API Reference Price

INTERMEDIATES

34 Intermediate Suppliers

34 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

287 FDF Dossiers, 80 FDA Orange Book, 109 Europe, 5 Canada, 30 Australia, 2 South Africa, 61 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 5MG BASE;80MG, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 6 DKSH, 5 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 3 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 25 Controlled & Modified Release, 23 Direct Compression, 18 Granulation, 18 Disintegrants & Superdisintegrants, 16 Thickeners and Stabilizers, 15 Lubricants & Glidants, 13 Solubilizers, 13 Film Formers & Plasticizers, 10 Taste Masking, 10 Co-Processed Excipients, 8 Parenteral, 7 Emulsifying Agents, 6 API Stability Enhancers, 6 Topical, 6 Rheology Modifiers, 6 Chewable & Orodispersible Aids, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

DIGITAL CONTENT

25 News #PharmaBuzz

25 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 102 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

26 APIs, 5 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

6 Others

6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

5 All

01 1Bystolic

02 4Bystolic/Byvalson

List of Suppliers

Product Main Page

01

Brand Name : Bystolic/Byvalson

AACR Annual meeting

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Nebivolol HCl

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2017 Revenue in Millions : 614

2016 Revenue in Millions : 641

Growth (%) : -4

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Bystolic/Byvalson

AACR Annual meeting

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Nebivolol HCl

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2018 Revenue in Millions : 586

2017 Revenue in Millions : 614

Growth (%) : -5%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Bystolic/Byvalson

AACR Annual meeting

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Nebivolol HCl

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2016 Revenue in Millions : 641

2015 Revenue in Millions : 646

Growth (%) : -1

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Bystolic/Byvalson

AACR Annual meeting

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 603

2018 Revenue in Millions : 586

Growth (%) : 3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Bystolic

AACR Annual meeting

Not Confirmed

Contact us
to update this info